Determination of esophageal squamous cell carcinoma and gastric adenocarcinoma on raw tissue using Raman spectroscopy.


Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
28 May 2023
Historique:
received: 12 12 2022
revised: 10 04 2023
accepted: 27 04 2023
medline: 26 6 2023
pubmed: 22 6 2023
entrez: 22 6 2023
Statut: ppublish

Résumé

Cancer detection is a global research focus, and novel, rapid, and label-free techniques are being developed for routine clinical practice. This has led to the development of new tools and techniques from the bench side to routine clinical practice. In this study, we present a method that uses Raman spectroscopy (RS) to detect cancer in unstained formalin-fixed, resected specimens of the esophagus and stomach. Our method can record a clear Raman-scattered light spectrum in these specimens, confirming that the Raman-scattered light spectrum changes because of the histological differences in the mucosal tissue. To evaluate the use of Raman-scattered light spectrum for detecting endoscop-ically resected specimens of esophageal squamous cell carcinoma (SCC) and gastric adenocarcinoma (AC). We created a Raman device that is suitable for observing living tissues, and attempted to acquire Raman-scattered light spectra in endoscopically resected specimens of six esophageal tissues and 12 gastric tissues. We evaluated formalin-fixed tissues using this technique and captured shifts at multiple locations based on feasibility, ranging from six to 19 locations 200 microns apart in the vertical and horizontal directions. Furthermore, a correlation between the obtained Raman scattered light spectra and histopathological diagnosis was performed. We successfully obtained Raman scattered light spectra from all six esophageal and 12 gastric specimens. After data capture, the tissue specimens were sent for histopathological analysis for further processing because RS is a label-free methodology that does not cause tissue destruction or alterations. Based on data analysis of molecular-level substrates, we established cut-off values for the diagnosis of esophageal SCC and gastric AC. By analyzing specific Raman shifts, we developed an algorithm to identify the range of esophageal SCC and gastric AC with an accuracy close to that of histopathological diagnoses. Our technique provides qualitative information for real-time morphological diagnosis. However, further

Sections du résumé

BACKGROUND BACKGROUND
Cancer detection is a global research focus, and novel, rapid, and label-free techniques are being developed for routine clinical practice. This has led to the development of new tools and techniques from the bench side to routine clinical practice. In this study, we present a method that uses Raman spectroscopy (RS) to detect cancer in unstained formalin-fixed, resected specimens of the esophagus and stomach. Our method can record a clear Raman-scattered light spectrum in these specimens, confirming that the Raman-scattered light spectrum changes because of the histological differences in the mucosal tissue.
AIM OBJECTIVE
To evaluate the use of Raman-scattered light spectrum for detecting endoscop-ically resected specimens of esophageal squamous cell carcinoma (SCC) and gastric adenocarcinoma (AC).
METHODS METHODS
We created a Raman device that is suitable for observing living tissues, and attempted to acquire Raman-scattered light spectra in endoscopically resected specimens of six esophageal tissues and 12 gastric tissues. We evaluated formalin-fixed tissues using this technique and captured shifts at multiple locations based on feasibility, ranging from six to 19 locations 200 microns apart in the vertical and horizontal directions. Furthermore, a correlation between the obtained Raman scattered light spectra and histopathological diagnosis was performed.
RESULTS RESULTS
We successfully obtained Raman scattered light spectra from all six esophageal and 12 gastric specimens. After data capture, the tissue specimens were sent for histopathological analysis for further processing because RS is a label-free methodology that does not cause tissue destruction or alterations. Based on data analysis of molecular-level substrates, we established cut-off values for the diagnosis of esophageal SCC and gastric AC. By analyzing specific Raman shifts, we developed an algorithm to identify the range of esophageal SCC and gastric AC with an accuracy close to that of histopathological diagnoses.
CONCLUSION CONCLUSIONS
Our technique provides qualitative information for real-time morphological diagnosis. However, further

Identifiants

pubmed: 37346148
doi: 10.3748/wjg.v29.i20.3145
pmc: PMC10280800
doi:

Substances chimiques

Formaldehyde 1HG84L3525

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3145-3156

Informations de copyright

©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Références

World J Gastrointest Oncol. 2020 Nov 15;12(11):1311-1324
pubmed: 33250963
Opt Lett. 2008 Apr 1;33(7):711-3
pubmed: 18382526
Curr Opin Biotechnol. 2009 Feb;20(1):63-73
pubmed: 19268566
Gastrointest Endosc. 2003 Mar;57(3):396-402
pubmed: 12612529
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Nov 15;261:120021
pubmed: 34116414
J Biomed Opt. 2012 Aug;17(8):081418
pubmed: 23224179
Photodiagnosis Photodyn Ther. 2021 Mar;33:102104
pubmed: 33212265
Analyst. 2010 Dec;135(12):3162-8
pubmed: 20941419
Photodiagnosis Photodyn Ther. 2019 Sep;27:156-161
pubmed: 31136828
Theranostics. 2019 Apr 13;9(9):2541-2554
pubmed: 31131052
Sci Transl Med. 2015 Feb 11;7(274):274ra19
pubmed: 25673764
Cancer Res. 2012 May 15;72(10):2491-500
pubmed: 22434431
Photodiagnosis Photodyn Ther. 2019 Jun;26:430-435
pubmed: 31082525
Bioanalysis. 2015;7(3):281-4
pubmed: 25697186
J Biophotonics. 2014 Sep;7(9):690-702
pubmed: 23821433

Auteurs

Hiroaki Ito (H)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan. h.ito@med.showa-u.ac.jp.

Naoyuki Uragami (N)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Tomokazu Miyazaki (T)

JSR Corporation, Tokyo 105-0021, Japan.

Yuto Shimamura (Y)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Haruo Ikeda (H)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Yohei Nishikawa (Y)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Manabu Onimaru (M)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Kai Matsuo (K)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Masayuki Isozaki (M)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

William Yang (W)

Bay Spec Inc., San Jose, CA 95131, United States.

Kenji Issha (K)

Fuji Technical Research Inc., Yokohama 220-6215, Japan.

Satoshi Kimura (S)

Department of Laboratory Medicine and Central Clinical Laboratory, Showa University Northern Yokohama Hospital, Yokohama 224-8503, Japan.

Machiko Kawamura (M)

Department of Hematology, Saitama Cancer Center, Inamachi 362-0806, Japan.

Noboru Yokoyama (N)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Miki Kushima (M)

Department of Pathology, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Haruhiro Inoue (H)

Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH